Imatinib Enhances Functional Outcome after Spinal Cord Injury

We investigated whether imatinib (Gleevec®, Novartis), a tyrosine kinase inhibitor, could improve functional outcome in experimental spinal cord injury. Rats subjected to contusion spinal cord injury were treated orally with imatinib for 5 days beginning 30 minutes after injury. We found that imatin...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Abrams, Mathew B., Nilsson, Ingrid, Lewandowski, Sebastian A., Kjell, Jacob, Codeluppi, Simone, Olson, Lars, Eriksson, Ulf
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2012
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3378614/
https://ncbi.nlm.nih.gov/pubmed/22723886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0038760
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller